Empagliflozin improves renal ischemia–reperfusion injury by reducing inflammation and enhancing mitochondrial fusion through AMPK–OPA1 pathway promotion

por Yang, Wenbo, Li, Xiaoli, He, Liujie, Zhu, Shuyang, Lai, Shicong, Zhang, Xiaopeng, Huang, Zixiong, Yu, Biyue, Cui, Chunping, Wang, Qiang
Publicado 2023

Could Metabolic Syndrome Be a Predictor of Survival Outcomes in Upper Tract Urothelial Carcinoma? A Propensity Score Matching Study in a Large Chinese Center

por Dai, Xiang, Wang, Fei, Du, Yiqing, Qin, Caipeng, Lai, Shicong, Song, Yuxuan, Huang, Zixiong, Han, Songchen, Zhang, Xiaopeng, Xu, Tao
Publicado 2022